Results 11 to 20 of about 6,573 (167)

Is Transthyretin a Regulator of Ubc9 SUMOylation? [PDF]

open access: yesPLoS ONE, 2016
Ageing and mutations of transthyretin (TTR), the thyroid hormones and retinol transporting protein lead to amyloidosis by destabilizing the structure of TTR.
Elżbieta Wieczorek   +6 more
doaj   +3 more sources

Crystal structure of UBA2(ufd)-Ubc9: insights into E1-E2 interactions in Sumo pathways. [PDF]

open access: yesPLoS ONE, 2010
Canonical ubiquitin-like proteins (UBLs) such as ubiquitin, Sumo, NEDD8, and ISG15 are ligated to targets by E1-E2-E3 multienzyme cascades. The Sumo cascade, conserved among all eukaryotes, regulates numerous biological processes including protein ...
Jing Wang   +7 more
doaj   +3 more sources

Autophagy regulates UBC9 levels during viral-mediated tumorigenesis.

open access: yesPLoS Pathogens, 2017
UBC9, the sole E2-conjugating enzyme required for SUMOylation, is a key regulator of essential cellular functions and, as such, is frequently altered in cancers. Along these lines, we recently reported that its expression gradually increases during early
Domenico Mattoscio   +14 more
doaj   +2 more sources

Observation of an E2 (Ubc9)-homodimer by crystallography [PDF]

open access: yesData in Brief, 2016
Post-translational modifications by the small ubiquitin-like modifiers (SUMO), in particular the formation of poly-SUMO-2 and -3 chains, regulates essential cellular functions and its aberration leads to life-threatening diseases (Geoffroy and Hay, 2009)
Aileen Y. Alontaga   +8 more
doaj   +2 more sources

Phosphorylation of Ubc9 by Cdk1 enhances SUMOylation activity. [PDF]

open access: yesPLoS ONE, 2012
Increasing evidence has pointed to an important role of SUMOylation in cell cycle regulation, especially for M phase. In the current studies, we have obtained evidence through in vitro studies that the master M phase regulator CDK1/cyclin B kinase ...
Yee-Fun Su   +4 more
doaj   +2 more sources

Elevated global SUMOylation in Ubc9 transgenic mice protects their brains against focal cerebral ischemic damage. [PDF]

open access: yesPLoS ONE, 2011
We have previously shown that a massive increase in global SUMOylation occurs during torpor in ground squirrels, and that overexpression of Ubc9 and/or SUMO-1 in cell lines and cortical neurons protects against oxygen and glucose deprivation.
Yang-Ja Lee   +5 more
doaj   +2 more sources

Elevated UBC9 expression and its oncogenic role in colorectal cancer progression and chemoresistance

open access: yesScientific Reports
Colorectal cancer (CRC) is a highly prevalent and fatal malignancy, with incidence and mortality rates rising globally. While elevated UBC9 expression has been implicated in various cancers, its specific role in CRC remains poorly understood.
Feng Li   +9 more
doaj   +2 more sources

Downregulation of UBC9 promotes apoptosis of activated human LX-2 hepatic stellate cells by suppressing the canonical NF-κB signaling pathway. [PDF]

open access: yesPLoS ONE, 2017
UBC9, the only known E2-conjugating enzyme involved in SUMOylation, is a key regulator in fibrosis. However, the roles of UBC9 in liver fibrosis remain unclear.
Sufen Fang   +6 more
doaj   +1 more source

Ubc9 Attenuates Myocardial Ischemic Injury Through Accelerating Autophagic Flux

open access: yesFrontiers in Pharmacology, 2020
AimsSUMOylation is a post-translational modification that plays a crucial role in the cellular stress response. We aimed to demonstrate whether and how the SUMO E2 conjugation enzyme Ubc9 affects acute myocardial ischemic (MI) injury.Methods and ...
Qing Xiao   +18 more
doaj   +1 more source

The UBC9/SUMO pathway affects E-cadherin cleavage in HPV-positive head and neck cancer

open access: yesFrontiers in Molecular Biosciences, 2022
Functional loss of E-cadherin is frequent during tumor progression and occurs through a variety of mechanisms, including proteolytic cleavage. E-cadherin downregulation leads to the conversion of a more malignant phenotype promoting Epithelial to ...
Maria Elisa Sabatini   +11 more
doaj   +1 more source

Home - About - Disclaimer - Privacy